Safarcík K, Brozmanová H, Bartos V, Jegorov A, Grundmann M
Department of Nuclear Medicine, University Hospital and Medico-Social Faculty, University of Ostrava, 17. listopadu 1790, 708 52 Ostrava, Czech Republic.
Clin Chim Acta. 2001 Aug 20;310(2):165-71. doi: 10.1016/s0009-8981(01)00570-8.
The aim of the work was to evaluate the possibility to estimate the level of cyclosporin A (CyA) metabolites as the difference of radioimmunoassay (RIA) non-specific and RIA specific methods.
Blood samples of renal transplant patients were analyzed by three different methods: RIA specific method (CYCLO-Trac, DiaSorin, USA) (RIA(SP)), RIA non-specific method (Immunotech, Czech Republic) (RIA(NS)), and high performance liquid chromatography (HPLC) method.
Although values obtained by RIA(SP) correlated well those obtained by HPLC (RIA(SP)=0.995.HPLC+9.68; r(2)=0.962, n=448), the results of HPLC methods were lower by 8%. The values obtained by RIA(NS) were 2.57 times higher than the values obtained by RIA(SP) (RIA(SP)=0.356RIA(NS); r(2)=0.713, n=448). The ratio (CyA+CyA metabolites)/(CyA) calculated as the ratio RIA(NS)/RIA(SP) values for 42 renal transplant patients was relatively stable for each particular patient. The sum of selected CyA metabolites (M1+M17+M21) measured by HPLC correlated well with that estimated from the difference of RIA(NS)-RIA(SP): HPLC(metab)=0.921.(RIA(NS)-RIA(SP))+21.3; (r(2)=0.746, n=448).
The combination of both the specific and non-specific methods for the determination of CyA presents an improved means for the TDM of CyA and CyA metabolites in renal transplant patients. Moreover, a combination of both methods can help to elucidate some unexpected events, such as the persistence of high cyclosporin blood levels.
本研究旨在评估通过放射免疫分析(RIA)非特异性方法与RIA特异性方法的差值来估算环孢素A(CyA)代谢物水平的可能性。
采用三种不同方法对肾移植患者的血样进行分析:RIA特异性方法(CYCLO-Trac,DiaSorin,美国)(RIA(SP))、RIA非特异性方法(Immunotech,捷克共和国)(RIA(NS))和高效液相色谱法(HPLC)。
尽管RIA(SP)所测值与HPLC所测值相关性良好(RIA(SP)=0.995·HPLC + 9.68;r² = 0.962,n = 448),但HPLC法的结果低8%。RIA(NS)所测值比RIA(SP)所测值高2.57倍(RIA(SP)=0.356RIA(NS);r² = 0.713,n = 448)。以42例肾移植患者的RIA(NS)/RIA(SP)值计算的(CyA + CyA代谢物)/(CyA)比值对每个特定患者而言相对稳定。HPLC测定的选定CyA代谢物(M1 + M17 + M21)之和与根据RIA(NS) - RIA(SP)差值估算的值相关性良好:HPLC(代谢物)=0.921·(RIA(NS) - RIA(SP)) + 21.3;(r² = 0.746,n = 448)。
特异性和非特异性方法相结合用于测定CyA,为肾移植患者的CyA及CyA代谢物的治疗药物监测提供了一种改进方法。此外,两种方法相结合有助于阐明一些意外情况,如环孢素血药浓度持续处于高水平。